Company logo

AMED - Amedisys, Inc.

NASDAQ -> Healthcare -> Medical Care Facilities
Baton Rouge, United States
Type: Equity

AMED price evolution
AMED
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $138.86 $94.02 $111.16 $69.1
Short term investments
Net receivables $313.37 $319.58 $278.79 $294.12
Inventory
Total current assets $496.94 $467.23 $426.54 $405.56
Long term investments
Property, plant & equipment $130.78 $127.47 $121.54 $118.56
Goodwill & intangible assets $1347.35 $1348.31 $1349.42 $1344.61
Total noncurrent assets $1563.23 $1560.19 $1555.86 $1541.4
Total investments
Total assets $2060.17 $2027.42 $1982.4 $1946.96
Current liabilities
Accounts payable $28.24 $34.55 $38.56 $40.02
Deferred revenue
Short long term debt $62.6 $61.48 $57.25 $52.41
Total current liabilities $473.72 $468.12 $462.4 $353.05
Long term debt $424.61 $428.73 $429.53 $433.03
Total noncurrent liabilities $466.67 $465.78 $459.24 $460.56
Total debt $487.21 $490.21 $486.78 $485.44
Total liabilities $940.39 $933.9 $921.64 $813.61
Shareholders' equity
Retained earnings $747.92 $728.6 $702.64 $782.92
Other shareholder equity
Total shareholder equity $1066.51 $1039.91 $1006.78 $1079.12
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $138.86 $54.13 $45.77 $83.36
Short term investments
Net receivables $313.37 $309.19 $274.96 $255.15
Inventory
Total current assets $496.94 $388.96 $356.68 $361.98
Long term investments
Property, plant & equipment $130.78 $118.88 $119.69 $117.16
Goodwill & intangible assets $1347.35 $1388.57 $1307.28 $1006.87
Total noncurrent assets $1563.23 $1587.28 $1500.28 $1205.21
Total investments
Total assets $2060.17 $1976.24 $1856.97 $1567.2
Current liabilities
Accounts payable $28.24 $43.73 $38.22 $42.67
Deferred revenue
Short long term debt $62.6 $49.02 $44.23 $40.54
Total current liabilities $473.72 $355.53 $374.28 $456.34
Long term debt $424.61 $419.42 $501.38 $266.5
Total noncurrent liabilities $466.67 $514.14 $506.36 $300.12
Total debt $487.21 $537.94 $545.61 $307.04
Total liabilities $940.39 $924.67 $880.64 $756.46
Shareholders' equity
Retained earnings $747.92 $757.67 $639.06 $429.99
Other shareholder equity $1.43
Total shareholder equity $1066.51 $1051.57 $931.35 $809.22
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $570.79 $556.24 $552.97 $556.39
Cost of revenue $321.42 $311.63 $297.45 $315.01
Gross Profit $249.37 $244.61 $255.51 $241.38
Operating activities
Research & development
Selling, general & administrative $135.12 $129.08 $125.5 $126.34
Total operating expenses $215.36 $202.4 $217.72 $199
Operating income $34.01 $42.21 $37.8 $42.38
Income from continuing operations
EBIT $37.73 $46.31 -$54.52 $42.56
Income tax expense $10.18 $12.33 $18.25 $9.8
Interest expense $8.23 $8.02 $7.5 $7.52
Net income
Net income $19.32 $25.96 -$80.28 $25.25
Income (for common shares) $19.32 $25.96 -$80.28 $25.25
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $2236.38 $2223.2 $2214.11 $2071.52
Cost of revenue $1245.51 $1260.42 $1233.36 $1185.37
Gross Profit $990.87 $962.77 $980.76 $886.15
Operating activities
Research & development
Selling, general & administrative $516.05 $508.79 $474.72 $449.45
Total operating expenses $834.48 $782 $728.84 $666.88
Operating income $156.39 $180.77 $251.91 $219.27
Income from continuing operations
EBIT $72.09 $183.38 $288.66 $220.28
Income tax expense $50.56 $42.55 $70.06 $25.64
Interest expense $31.27 $22.23 $9.53 $11.04
Net income
Net income -$9.75 $118.61 $209.07 $183.61
Income (for common shares) -$9.75 $118.61 $209.07 $183.61
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $19.32 $25.96 -$80.28 $25.25
Operating activities
Depreciation $14.46 $14.52 $14.55 $14.32
Business acquisitions & disposals $47.44
Stock-based compensation $9.4 $7.24 $9.11 $3.27
Total cash flows from operations $60.31 -$9.84 $60.76 $25.96
Investing activities
Capital expenditures -$1.86 -$0.98 -$1.29 -$1.35
Investments $0.15
Total cash flows from investing -$2.04 -$1.05 -$7.75 $45.9
Financing activities
Dividends paid
Sale and purchase of stock $0.87 $1.01 $0.82
Net borrowings -$8.9 -$6.12 -$5.68 -$55.31
Total cash flows from financing -$13.43 -$6.25 -$10.95 -$56.89
Effect of exchange rate
Change in cash and equivalents $44.85 -$17.14 $42.06 $14.97
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$9.75 $118.61 $209.07 $183.61
Operating activities
Depreciation $57.84 $70.96 $71.27 $67.94
Business acquisitions & disposals $47.44 -$71.95 -$269.96 -$298.96
Stock-based compensation $29.02 $16.56 $23.81 $26.73
Total cash flows from operations $137.19 $133.28 $188.89 $288.95
Investing activities
Capital expenditures -$5.48 -$6.1 -$6.16 -$5.25
Investments $0.15 -$15.64 -$5.2 $17
Total cash flows from investing $35.06 -$94.49 -$281.61 -$287.11
Financing activities
Dividends paid
Sale and purchase of stock $2.7 -$11.2 -$93.86 $9.89
Net borrowings -$76.01 -$13.3 $227.38 -$29.25
Total cash flows from financing -$87.52 -$30.43 $55.13 -$14.98
Effect of exchange rate
Change in cash and equivalents $84.73 $8.36 -$37.59 -$13.13
Fundamentals
Market cap $2.97B
Enterprise value $3.32B
Shares outstanding 32.67M
Revenue $2.24B
EBITDA $129.93M
EBIT $72.09M
Net Income -$9.75M
Revenue Q/Q 1.55%
Revenue Y/Y 0.59%
P/E ratio -304.86
EV/Sales 1.48
EV/EBITDA 25.55
EV/EBIT 46.05
P/S ratio 1.33
P/B ratio 2.79
Book/Share 32.65
Cash/Share 4.25
EPS -$0.30
ROA -0.49%
ROE -0.93%
Debt/Equity 0.88
Net debt/EBITDA 6.17
Current ratio 1.05
Quick ratio 1.05